Affordable Access

Publisher Website

Bromocriptine protects mice against 6-hydroxydopamine and scavenges hydroxyl free radicals in vitro

Authors
Journal
Brain Research
0006-8993
Publisher
Elsevier
Publication Date
Volume
657
Identifiers
DOI: 10.1016/0006-8993(94)90969-5
Keywords
  • Parkinson'S Disease
  • 6-Hydroxydopamine
  • Free Radical
  • Hydroxyl Radical
  • Bromocriptine
  • L-Dopa
  • Neuroprotection
Disciplines
  • Medicine

Abstract

Abstract Pretreatment with bromocriptine (5 mg/kg, i.p., 7 days) completely protected against the decrease in mouse striatal dopamine and its metabolites induced by intraventricular injection of 6-hydroxydopamine after intraperitoneal administration of desipramine, but similar pretreatment with l-DOPA/carbidopa (75/7.5 mg/kg, i.p., 7 days) showed only partial protective effect. Furthermore, in an in vitro system that generated ·OH from FeSO 4-H 2O 2, bromocriptine dose-dependently reduced the number of ·OH radicals. These findings indicate that bromocriptine has a neuroprotective effect against neurotoxins such as 6-hydroxydopamine, probably due, in part, to its hydroxyl radical scavenging activity and inhibiting effect on dopamine turnover rate. This suggests that early introduction of bromocriptine in the therapy of Parkinson's disease may be superior to treatment with l-DOPA alone.

There are no comments yet on this publication. Be the first to share your thoughts.